|
|
- 2019
Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancerDOI: 10.1186/s12935-019-0745-x Keywords: Bone metastases secondary to prostate, Zoledronate, Direct in vitro treatment, Low doses, Cellular assays Abstract: The online version of this article (10.1186/s12935-019-0745-x) contains supplementary material, which is available to authorized users
|
